For md dermatology theory exam make botes on - skin changes in gout

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

gout AND skin manifestations

Searching the Web

cutaneous manifestations gout tophi clinical features reliable dermatology source

Searching Images

gouty tophi clinical skin lesions ear helix elbow fingers

Reading File
Reading File
Reading File
Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC4527619

Skin changes in gout

Definition

Gout is a crystal deposition disease caused by monosodium urate (MSU) crystals. Cutaneous involvement is mainly due to deposition of MSU in dermis, subcutis, cartilage, tendon, bursae, and periarticular tissues.

1. Cutaneous changes during an acute gout attack

Usually occur over an acutely inflamed joint, classically the first metatarsophalangeal joint (podagra).
  • Marked erythema, warmth, tenderness, and oedema of overlying skin.
  • Skin may look tense and shiny due to oedema.
  • As the acute inflammation resolves, the skin often becomes violaceous.
  • Desquamation or peeling may follow as oedema subsides.
  • Severe attacks may simulate cellulitis or septic arthritis.
Dermatology 2-Volume Set, 5e, p. 934.

2. Chronic tophaceous gout

This is the principal dermatological manifestation of gout.

Tophus

A tophus is a localized collection of MSU crystals surrounded by a chronic granulomatous inflammatory reaction.

Time of appearance

  • Generally develops after long-standing, insufficiently controlled hyperuricaemia and recurrent attacks.
  • Commonly occurs around 10 years after onset of gout.
  • Rarely, tophi may be the first manifestation, including in patients with a normal serum urate level.

Morphology

Tophi may present as:
  • Firm, painless dermal or subcutaneous papules and nodules
  • Fusiform swellings
  • Smooth or multilobulated masses
  • Lesions ranging from pinhead size to very large deforming nodules
  • Colour: skin-coloured, white-yellow, cream-coloured, or erythematous
  • Skin may be thin and translucent, with prominent overlying vessels
  • Deep tophi may not be readily visible clinically

Typical sites

Tophi occur preferentially in relatively cool, poorly vascularised, or pressure-prone areas:
  • Helix and antihelix of ear, pinna
  • Skin over small joints of fingers and toes, especially DIP and PIP joints
  • Finger pads and palmar/ventral digital creases
  • Olecranon bursa and extensor elbow
  • Prepatellar region and knee
  • Achilles tendon and other tendon sheaths
  • Feet and first MTP joint
In women, deposits may develop over Heberden and Bouchard nodes, potentially mimicking nodal osteoarthritis.
Dermatology 2-Volume Set, 5e, pp. 934-935.

3. Ulceration and discharge

With progression, a tophus may:
  • Soften and break down
  • Ulcerate
  • Discharge clear fluid containing white flecks, or thick white, gritty, chalk-like material
  • Heal and subsequently recur or break down again
Ulcerated or draining tophi may become secondarily infected. They may cause pain, functional limitation, cosmetic disfigurement, and chronic non-healing ulcers.

4. Unusual cutaneous forms of gout

A. Intradermal or pustular tophi

  • Fine intradermal deposits can clinically resemble pustules.
  • They may appear as multiple white-yellow papules containing urate material.
  • Can occur without prominent arthritis in rare cases.

B. Disseminated cutaneous gout

  • Multiple widespread papules, nodules, or pustule-like lesions due to diffuse cutaneous urate deposition.
  • May be seen in severe, chronic poorly controlled disease.

C. Gouty panniculitis

A rare manifestation caused by MSU deposition in the subcutaneous fat.
Clinical features
  • Firm erythematous or skin-coloured subcutaneous nodules and plaques
  • Usually on the lower limbs
  • May be painful or tender
  • Irregular surface and well-defined borders
  • Can ulcerate and discharge chalky white material
It may mimic erythema nodosum, other panniculitides, calcinosis cutis, or infection. Renal impairment and severe hyperuricaemia are important associations.

D. Atypical locations

Rarely, tophi can involve:
  • Nasal bridge
  • Eyelids and ocular structures
  • Breast
  • Larynx
  • Heart valves

5. Histopathology

Typical findings

  • Dermal or subcutaneous deposits of amorphous material.
  • Needle-shaped clefts represent dissolved MSU crystals in routinely processed specimens.
  • Foreign-body granulomatous response with:
    • Histiocytes
    • Multinucleated giant cells
    • Chronic inflammatory infiltrate
    • Fibrosis in older lesions

Polarized microscopy

  • Fresh material shows long, slender needle-shaped MSU crystals.
  • Crystals are negatively birefringent under compensated polarized light.

Important processing point

Routine formalin fixation can dissolve urate crystals. For optimal crystal preservation:
  • Use absolute ethanol or an ethanol-based fixative such as Carnoy fluid.
  • Fresh or frozen material may be examined under polarized light.
  • In formalin-fixed tissue, unstained thick sections may still demonstrate crystals or crystal clefts.
Dermatology 2-Volume Set, 5e, p. 935.

6. Differential diagnosis of cutaneous tophi

ConditionDistinguishing point
Rheumatoid nodulesFirm extensor nodules in rheumatoid arthritis; palisading granulomas histologically, no urate crystals
XanthomasYellow lipid-rich papules/nodules; associated dyslipidaemia
Calcinosis cutisCalcium deposits, hard whitish nodules; calcium demonstrable with special stains
Subepidermal calcified noduleSolitary hard calcified lesion, often in children
Multicentric reticulohistiocytosisPapulonodular lesions with destructive polyarthritis
Synovial cyst/ganglionCystic and translucent rather than chalky, firm deposits
Heberden or Bouchard nodesBony osteoarthritic enlargement, especially at DIP/PIP joints
Rheumatic fever nodulesUsually in children, transient and associated with rheumatic fever

7. Diagnostic approach in dermatology

  • Consider gout in a patient with chronic hyperuricaemia, recurrent arthritis, renal impairment, diuretic use, or a history of gout who presents with yellow-white nodules or chalky ulceration.
  • Serum urate supports the diagnosis but does not confirm it and can be normal.
  • Best confirmation: aspiration or biopsy showing negatively birefringent needle-shaped MSU crystals.
  • Exclude secondary infection in an ulcerated or discharging lesion by Gram stain and culture where indicated.

8. Treatment principles relevant to skin lesions

  • Long-term urate-lowering therapy with sustained serum urate reduction is the key treatment.
  • With adequate urate control, tophi may partly or completely regress.
  • Manage ulcerated lesions with wound care and treatment of secondary infection if present.
  • Surgical debulking/excision may be considered for large lesions causing ulceration, compression, severe deformity, functional impairment, or diagnostic uncertainty.

Exam takeaway

Tophi are firm white-yellow dermal or subcutaneous deposits of MSU, classically affecting the ear helix, digits, olecranon region, and Achilles tendon. Chronic lesions may ulcerate and discharge chalky material. Histology shows needle-shaped crystal clefts with a foreign-body granulomatous reaction; MSU crystals are negatively birefringent.
This is a shared conversation. Sign in to Orris to start your own chat.